Multi-omics profiling of human biofluids from LRRK2 mutation carriers are beginning to identify additional pathways that are altered in LRRK2-PD and LRRK2 non-manifesting carriers when compared to iPD and healthy controls96,97. The gene discussed is LRRK2; the disease is Parkinson disease.